Analgesic Efficacy of Sacral Neuromodulation for Pelvic Cancer Pain: A Preliminary Report
Unknown statusNot applicableNCT04549818
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
in this trial, we will test the analgesic efficacy of sacral neuromodulation for patients with pelvic cancer, complaining of chronic pelvic pain in comparison to medical treatment.
Study details
- Official title
- Does Sacral Neuromodulation Relieve Chronic Pelvic Cancer Pain, Compared With Medical Treatment?
- Conditions
- Interventions
- Device: sacral neuromodulation
- Sponsor
- Assiut University
- Start date
- 2020-09-10
- Primary completion
- 2021-09-10
- Sex
- All
- Age range
- from 18 Years to 70 Years
- Results posted
- No results posted in this snapshot
- Total sites listed
- 0
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Age, 18-70 * Pain localized to the pelvic and perineal region * The pain is due to pelvic cancer or chronic pelvic pain after pelvic surgery for cancer * The intensity of pain assessed by VAS (visual analogue pain scale) \> 7 * Importantly, the included participants should gain \> 50% reduction of their pain in response to sacral roots block, S2,3 and 4 with bupivacaine 0.5%, 2 ml for each root Exclusion Criteria: * Coagulopathy * Infection at site of maneuver * Abnormal Psychological behavior that interfere with integrity of obtained data
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04549818